STAT

MAY 21, 2024

BATON ROUGE, La. — The surgery was supposed to alleviate worry, but now, years later, Whitney Carter’s mind kept flicking back to it, wondering if it could be undone. She sometimes descended into these moods, taciturn, withdrawn, as if all hope had gone extinct. She sat on the couch in the half-light, blinds shut against the heat. The whole thing made her feel less than, like some essential part of her had been removed.

363

363

PharmaVoice

MAY 21, 2024

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

291

291

STAT

MAY 21, 2024

Scientists from the University of Washington and the Fred Hutchinson Cancer Center have managed to generate a full genetic sequence of H5N1 virus from milk, a development they suggest means commercially purchased milk products could be used to monitor the progress of the bird flu outbreak in dairy cattle and to check for important changes in the virus over time.

363

363

PharmaVoice

MAY 21, 2024

Heather Dean discusses the company’s neuroscience pipeline in epilepsy and narcolepsy and moving from a mass market to a rare disease mentality.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 21, 2024

The Centers for Disease Control and Prevention asked local and state health officials Tuesday to maintain flu surveillance operations at peak-season levels over the summer in a bid to remain watchful for any signs of human-to-human spread of the H5N1 bird flu virus. Flu surveillance activity is generally conducted at low levels during the late spring and summer months, in recognition of the fact that as temperatures rise, transmission of seasonal flu viruses drops to minimal levels in the Northe

355

355

The Pharmacist

MAY 21, 2024

Pharmacists and pharmacy technicians transitioning to new roles in primary care are to be supported with a structured induction programme developed by Health Education and Improvement Wales (HEIW), it has said. The commitment came as part of the Welsh Government’s Strategic Workforce Plan for Primary Care for 2024/25-2029/30, published last week. The plan also committed […] The post GP pharmacists in Wales to get structured induction programme appeared first on The Pharmacist.

Pharmacy Technician 127

Pharmacy Technician 127

Safe Biologics

MAY 21, 2024

ASBM’s Michael Reilly: Preserve the US Interchangeable Standard that Has Helped Drive Physician and Patient Confidence in Biosimilars In an April interview with EndpointsNews , an FDA official called on Congress to eliminate the distinction between biosimilars (which can be prescribed in place of their reference products by a physician) and “interchangeable” biosimilars, which can be substituted by pharmacists the way generics are.

Biosimilars 100

Biosimilars Documentation 100

STAT

MAY 21, 2024

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday. The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

269

269

The Pharmacist

MAY 21, 2024

Three-quarters of people with a learning disability are not currently on the general practice learning disability register, a new report published today by the Women and Equalities Committee (WEC) has suggested. MPs on the cross-party committee warned that people with a learning disability and autistic people faced significant health inequalities, including an ‘unacceptable level of […] The post Three-quarters of people with learning disability not registered for GP practice support appear

123

123

STAT

MAY 21, 2024

I am both excited and terrified by the entrance of artificial intelligence into my primary care practice. AI’s enormous potential to help clinicians become more focused on patients, available, diagnostically accurate, and efficient feels like a dream. Yet memories of the nightmarish introduction of the electronic heath record into clinicians’ work lives looms like a dark cloud.

266

266

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

MAY 21, 2024

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

119

119

STAT

MAY 21, 2024

CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030. Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs.

258

258

pharmaphorum

MAY 21, 2024

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.

114

114

STAT

MAY 21, 2024

Dear Readers, I want to bring your attention to a deeply disturbing but vital series of stories STAT is publishing beginning today.  It reveals that an injustice often relegated to the distant past persists to this day: For decades, physicians have steered sickle cell patients toward sterilization, their stories echoing the ugly history of eugenics in America.

255

255

pharmaphorum

MAY 21, 2024

AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.

119

119

STAT

MAY 21, 2024

“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering over virtual care.” These are just a few of the doomsday views sparked by the news that Optum and Walmart are shutting down their virtual care businesses. Many industry observers, connecting the dots to the current struggles of legacy telehealth providers , have concluded that virtual care is in trouble.

245

245

pharmaphorum

MAY 21, 2024

Despite the rate of bipolar disorder being the same among Black Americans as other Americans, there exists a significant disparity in diagnosis and subsequent treatment. Many Black Americans with bipolar disorder remain undiagnosed and untreated.

110

110

STAT

MAY 21, 2024

Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers. AltruBio, a Bay Area biotech, is betting it can help patients suffering from autoimmune and inflammatory diseases by taking the opposite tack: pumping the brakes on runaway immune responses.

Immunity 225

Immunity Immunization Drug Development 225

The Pharmacist

MAY 21, 2024

More than one in 20 adults in the UK has a clinically confirmed food allergy, according to a detailed study commissioned by the Food Standards Agency. The Patterns and Prevalence of Adult Food Allergy report also found that around 36% of people have a self-reported adverse reaction to food. For UK adults, peanuts and tree nuts like […] The post One in 20 adults in UK have clinically confirmed food allergy appeared first on The Pharmacist.

Adverse Reactions 105

Adverse Reactions 105

STAT

MAY 21, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Please take some time today to read  this story  from my colleague Eric Boodman, who spent a year investigating how doctors are pushing sickle cell patients to get unwanted sterilizations. This is the first story in a new series from STAT called  Coercive Care.

Drug Pricing 208

Drug Pricing Drug Development 208

BioPharma Dive

MAY 21, 2024

The U.K. pharma expects to launch 20 new drugs by then, among them complex medicines for cancer as well as treatments for weight loss.

119

119

STAT

MAY 21, 2024

Good morning from the Pharmalittle campus, where I’m filling in for Ed. Normally, I’m the type of person who used to press snooze 10 times in their dorm room before running across campus to arrive for class barely on time. But this week, I’m up early. The scent of strong, dark roast espresso is just beginning to travel up my nasal passages to my brain.

185

185

pharmaphorum

MAY 21, 2024

Discover how the Quillaja saponaria tree is revolutionising vaccine development as a sustainable, natural adjuvant. Learn about BSI's innovative work harnessing the power of this remarkable plant.

Vaccines 101

Vaccines 101

PioneerRx

MAY 21, 2024

As independent pharmacy continues to go clinical, you’ve probably found yourself considering adding a service, expanding a program, or in this case, tacking on.

Independent Pharmacies 105

Independent Pharmacies 105

World Pharma News

MAY 21, 2024

Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching an expected 20 new medicines before the end of the decade. To drive sustained growth beyond 2030, the Company will continue investing in transformative new technologies and platforms that will shape the future of medicine.

99

99

Drug Patent Watch

MAY 21, 2024

Annual Drug Patent Expirations for BELSOMRA Belsomra is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier.

105

105

pharmaphorum

MAY 21, 2024

Going against the advice of the CHMP, the EU has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy should stay on the market

106

106

BioPharma Dive

MAY 21, 2024

Since pivoting from oncology, the startup has raised close to $300 million and advanced an ulcerative colitis drug into mid-stage testing.

Immunity 111

Immunity Immunization 111

pharmaphorum

MAY 21, 2024

Digital investment in the pharma sector is continuing at a steady pace but could fall behind what is needed to deliver true transformation of their businesses.

102

102

BioPharma Dive

MAY 21, 2024

The U.K. drugmaker aims to catch up in developing new tumor-fighting technologies — areas where it has lagged behind leaders like Novartis and J&J.

102

102

Outsourcing Pharma

MAY 21, 2024

A âtransformationalâ treatment for people with severe alcohol-associated hepatitis (AH) has today (May 21) been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA).

96

96

Express Pharma

MAY 21, 2024

Glenmark Specialty S.A. (Glenmark), a subsidiary of Glenmark Pharmaceuticals., announced an exclusive marketing and distribution agreement with BeiGene. Under this agreement, Glenmark will register and commercialise BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India. Tislelizumab is a novel anti-PD-1 monoclonal antibody approved by NMPA, EMA and FDA for the treatment of advanced or metastatic esophageal squamous cell carcinoma and broad development for the treatment of va

93

93

Pharma Times

MAY 21, 2024

The network will support the development, evaluation and adoption of innovative health and care technology

113

113

Express Pharma

MAY 21, 2024

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. Sanofi will leverage this partnership to provide access to proprietary data to develop AI models.

Drug Development 87

Drug Development 87

Outsourcing Pharma

MAY 21, 2024

Clinical Trials Day is organized and promoted by the Association of Clinical Research Professionals (ACRP) for the last ten years.

105

105